Table 4. Outcomes data in the meta-analysis.
| Study | Patients, n | Rebleeding % (n) | Mortality % (n) | Additional intervention % (n) | |||
| TAE | Surg | TAE | Surg | TAE | Surg | ||
| Ang 2012 13 | 54 | 42 (8 /19) |
14 (5 /35) |
26 (5 /19) |
34 (12 /35) |
32 (6 /19) |
9 (3 /35) |
| Wong 2011 14 | 88 | 34 (11 /32) |
13 (7 /56) |
25 (8 /32) |
30 (17 /56) |
25 (8 /32) |
9 (5 /56) |
| Venclauskas 2010 15 | 74 | 15 (3 /20)1 |
8 (4 /50) |
21 (5 /24) |
22 (11 /50) |
8 (2 /24) |
6 (3 /50) |
| Larssen 2008 17 | 46 | 28 (10 /36) |
20 (2 /10) |
19 (7 /36) |
20 (2 /10) |
n.a. | n.a. |
| Erikson 2008 18 | 91 | 25 (10 /40) |
18 (9 /51) |
3 (1 /40) |
14 (7 /51) |
13 (5 /40) |
6 (3 /51) |
| Ripoll 2004 16 | 70 | 29 (9 /31) |
23 (9 /39) |
26 (8 /31) |
21 (8 /39) |
16 (5 /31) |
31 (12 /39) |
surg, surgery; n.a., not available.
1
Total number of patients, in cases with missing data.